CIDARA THERAPEUTICS, INC. Restricted Cash, Current
CIDARA THERAPEUTICS, INC. had Restricted Cash, Current of $6.34 million as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:RestrictedCashCurrent · last filed 2025-11-06
- 2025-09-30: Restricted Cash, Current $6.34M.
- 2025-06-30: Restricted Cash, Current $6.34M.
- 2025-03-31: Restricted Cash, Current $6.34M.
- 2024-12-31: Restricted Cash, Current $6.35M.
| Period end | Restricted Cash, Current |
|---|---|
| 2025-09-30 | $6.34M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $6.34M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $6.34M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $6.35M 10-Q · filed 2025-11-06 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-06 |
| 2022-12-31 | $0.00 10-K · filed 2023-03-23 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-03 |
| 2022-06-30 | $370.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $1.48M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $2.59M 10-K · filed 2023-03-23 |
| 2021-09-30 | $3.70M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $4.82M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $5.93M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $7.04M 10-K · filed 2022-03-07 |
| 2020-09-30 | $8.15M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $9.26M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $10.00M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $10.00M 10-K · filed 2021-02-25 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-04 |